| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wherley Joel L | CEO - Vitas Healthcare | 255 EAST FIFTH STREET, SUITE 2600, CINCINNATI | Joel L Wherley | 2025-08-27 | 0002083070 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CHE | Capital Stock | 659 | Aug 27, 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CHE | Stock Option (right to buy with tandem tax withholding) | Aug 27, 2025 | Capital Stock | 6.96K | $509.46 | Direct | F1 | ||||||
| holding | CHE | Stock Option (right to buy with tandem tax withholding) | Aug 27, 2025 | Capital Stock | 8.38K | $597.70 | Direct | F2 | ||||||
| holding | CHE | Performance Stock Unit | Aug 27, 2025 | Capital Stock | 220 | Direct | F3, F4 | |||||||
| holding | CHE | Performance Stock Unit | Aug 27, 2025 | Capital Stock | 220 | Direct | F4, F5 | |||||||
| holding | CHE | Performance Stock Unit | Aug 27, 2025 | Capital Stock | 223 | Direct | F4, F6 | |||||||
| holding | CHE | Performance Stock Unit | Aug 27, 2025 | Capital Stock | 223 | Direct | F4, F7 | |||||||
| holding | CHE | Performance Stock Unit | Aug 27, 2025 | Capital Stock | 312 | Direct | F4, F8 | |||||||
| holding | CHE | Performance Stock Unit | Aug 27, 2025 | Capital Stock | 312 | Direct | F4, F9 |
| Id | Content |
|---|---|
| F1 | Vesting in three equal annual installments commencing 10/25/2024. |
| F2 | Vesting in three equal annual installments commencing 10/22/2025. |
| F3 | The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2023 through December 31, 2025 with the determination of such performance level to be made no later than March 15, 2026 and earned shares of Capital Stock to be delivered thereafter. |
| F4 | Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock. |
| F5 | The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2023 through December 31, 2025 with the determination of such performance level to be made no later than March 15, 2026 and earned shares of Capital Stock to be delivered thereafter. |
| F6 | The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2024 through December 31, 2026 with the determination of such performance level to be made no later than March 15, 2027 and earned shares of Capital Stock to be delivered thereafter. |
| F7 | The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2024 through December 31, 2026 with the determination of such performance level to be made no later than March 15, 2027 and earned shares of Capital Stock to be delivered thereafter. |
| F8 | The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2025 through December 31, 2027 with the determination of such performance level to be made no later than March 15, 2028 and earned shares of Capital Stock to be delivered thereafter. |
| F9 | The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2025 through December 31, 2027 with the determination of such performance level to be made no later than March 15, 2028 and earned shares of Capital Stock to be delivered thereafter. |